Associated Papers
The effect of HLA genotype on disease onset and severity in CTLA-4 insufficiency.
Posadas-Cantera S et al.
Frontiers in Immunology, 2024
Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
Krausz M et al.
Frontiers in Immunology, 2022
Establishing the Molecular Diagnoses in a Cohort of 291 Patients With Predominantly Antibody Deficiency by Targeted Next-Generation Sequencing: Experience From a Monocentric Study.
Rojas-Restrepo J et al.
Frontiers in Immunology, 2021
What did we learn from CTLA-4 insufficiency on the human immune system?
Mitsuiki N et al.
Immunological Reviews, 2019
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.
Schwab C et al.
The Journal of Allergy and Clinical Immunology, 2018
Evaluating the Genetics of Common Variable Immunodeficiency: Monogenetic Model and Beyond.
de Valles-Ibáñez G et al.
Frontiers in Immunology, 2018
29867916 (PubMed )
Supplement: data_sheet_1.PDF
Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers.
Egg D et al.
Frontiers in Immunology, 2018
Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations.
Verma N et al.
Clinical and Experimental Immunology, 2017
CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency.
Lo B et al.
Blood, 2016
Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.
Schubert D et al.
Nature Medicine, 2014
Select a paper to view details